AI MARKET SCANNING

Vistagen Therapeutics Inc

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -2.91%
MAX GAP RECORD -19.23%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $VTGN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE)
+0.00%
Jun 15, 2026 Earnings Release 2026-06-15 (AFTER CLOSE)
+1.75%
Feb 12, 2026 Earnings Release 2026-02-12 (AFTER CLOSE)
-12.73%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
-2.11%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+1.47%
Jun 17, 2025 Earnings Release 2025-06-17 (AFTER CLOSE)
-2.52%
Feb 13, 2025 Earnings Release 2025-02-13 (AFTER CLOSE)
+3.51%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.7%
Bullish Gaps (4)
Bearish Gaps (6)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $VTGN

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Vistagen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗